Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

PKA-Dependent Autophagy Control in Aspergillus fumigatus Pathogenesis

$2.51M USD

Funder NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization Arkansas Children'S Hospital Res Inst
Country United States
Start Date Jul 05, 2024
End Date May 31, 2026
Duration 695 days
Number of Grantees 2
Roles Co-Investigator; Principal Investigator
Data Source NIH (US)
Grant ID 10984183
Grant Description

Invasive aspergillosis (IA), caused by the fungus Aspergillus fumigatus, is a leading infectious cause of death in immunocompromised patients. A significant barrier to deciphering the mechanisms of pathogenesis and developing effective antifungals is a lack of understanding of the regulation of A. fumigatus growth leading to

invasive disease. Cellular recycling mediated via autophagy-associated proteins is a key catabolic pathway and critical to invasive fungal growth and virulence in the well-known nutrient-limited host environment. Protein kinase A (PKA) is vital for growth and virulence of numerous fungal pathogens. However, the underlying basis for its

regulation of pathogenesis remains poorly understood in any species. Our A. fumigatus PKA-dependent whole proteome and phosphoproteome studies employing advanced mass spectroscopic (MS) approaches identified numerous previously undefined PKA-regulated proteins in catabolic pathways. Preliminary characterization of

two such novel direct PKA target proteins, Atg24 and Not4, demonstrated their requirement for A. fumigatus virulence and also revealed functional importance of PKA-dependent phosphorylation of specific target sites. We have identified and prioritized more than 30 autophagy-associated proteins as likely novel PKA-regulated

effectors, and will now characterize the top 6 priority proteins with regard to their roles in fungal growth and pathogenesis, as well as their regulation by PKA. Our overall objective is to leverage our robust PKA whole proteomic and phosphoproteomic data to define fungal-specific mechanisms of PKA control over autophagy

function and validate these PKA-regulated effectors’ novel contributions to fungal virulence. In Aim 1, we will define PKA control over autophagy by validating PKA-dependent phosphorylation of prioritized phosphoregulated effectors via MS analysis and expression-regulated effectors via qRT-PCR. We will

characterize the role of each PKA effector in fungal growth and stress responses through deletion and phosphosite mutagenesis approaches. We will also perform structural elucidation of PKA-effector phosphoregulation and function using molecular modeling and molecular dynamics simulations. In Aim 2, we

will validate the roles of PKA-regulated autophagy proteins in virulence and host-pathogen interaction using our murine model of invasive aspergillosis to assess their impact on mortality, fungal burden and host lung tissue damage via histological analysis. We will also assess the impact of PKA-regulated proteins on both the pathogen

and host response to infection by expression profiling of A. fumigatus autophagy marker genes, as well as simultaneous examination of the host immune cytokine response during infection with wild-type and mutant strains. PKA regulates catabolic processes critical to fungal growth, yet an understanding of PKA regulation of

autophagy pathways is lacking in any organism. We will define novel PKA-dependent regulation of newly- identified fungal-specific autophagy-associated proteins and provide critical insight into future exploitation of PKA-dependent control over A. fumigatus disease.

All Grantees

Arkansas Children'S Hospital Res Inst

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant